Status:
COMPLETED
AD01 Follow up Extension Visit
Lead Sponsor:
Affiris AG
Conditions:
Alzheimer´s Disease
Eligibility:
All Genders
Brief Summary
Patients who were vaccinated with AFFITOPE AD01 during AFFiRiS001 will undergo a long-term follow-up period to get more information regarding the safety profile of AFFITOPE AD01.
Eligibility Criteria
Inclusion
- Written informed consent signed and dated by the patient or the patient's legal representative and the caregiver.
- Patients having participated in AFFiRiS 001 and AFF003 and having received ≥1 vaccination with AFFITOPE AD01
- Availability of a partner/caregiver knowing the patient
Exclusion
- Patients having received no vaccination with AFFITOPE AD01
- History of questionable compliance to visit schedule
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT01225809
Start Date
September 1 2010
End Date
January 1 2011
Last Update
January 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univ. Klinik für Neurologie
Vienna, Austria, 1090